《亞洲股市》印度及港股升0.5%及0.6% 惟印尼下挫1.6%
美股期貨全面升0.1%-0.2%,昨晚逆升納指期貨續跑贏報14,192,升35點。亞太區股市個別發展,印尼最傷,報5,972,跌1.6%,連跌第三天。泰國、新加坡、台灣及菲律賓股市跌0.1%-0.5%,後者最傷報6,853,連跌第二天。
滬指半日低收3,508,回落0.5%,深成承昨天回升1%勢,早段曾再升1%至14,616無以為繼,掉頭低見14,449,半日收14,470,微跌1點。
相反,印度孟買指數扭兩連跌,報52,568,回升0.5%。澳洲200回升0.4%曾見7,403,逼近日前紀錄高位7,404。日經、南韓、馬來西亞及新西蘭股市均升不足0.4%,前者高見29,136,現造29,044,僅回升0.1%。
港股連續第二天反彈,今早在比亞迪(01211.HK)、藥明生物(02269.HK)、美團(03690.HK)、盈喜安踏(02020.HK)、舜宇(02382.HK)及日前料中績倍增的信義光能(00968.HK)升逾2%-8%推動,曾升272點至28,830,現造28,736,續升177點或0.6%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.